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ABSTRACT:

A strain of Escherichia coli was genetically modified to co-express human

heme oxygenase-1 and ferritin. The E. coli were then grown with varying amounts of
hemin to see if the iron released upon degradation of the hemin by heme oxygenase-1 is
loaded into ferritin. Following incubation, the ferritin was purified and the amount of
iron loaded into ferritin determined.

It was found that ferritin purifed from E. coli

expressing human heme oxygenase-1 contained more iron than E. coli that did not
contain human heme oxygenase-1. It was concluded that some of the iron released upon
degradation of hemin by heme oxygenase-1 can be sequestered by ferritin.

INTRODUCTION
Recent research has shown that reactive oxygen species (ROS), such as the
hydroxyl radical or superoxide, can be the causation of various diseases [ 1]. The
presence of free iron in cellular environments is one source of ROS, which produces the
hydroxyl radical according to the Fenton reaction:

The hydroxyl radical formed then reacts with surrounding substances, damaging DNA,
proteins, or other molecules.

Although iron can catalyze the deleterious oxidation of

lipids, DNA, proteins, and other biomolecules [2], it is essential for various biochemical
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processes.

From oxygen carriers to electron transport chain proteins , iron plays many

roles essential for life. While the Food and Drug Administration suggests that 18
milligrams of iron should be consumed daily in order to replenish the body's iron, many
people (approximately 500 million around the globe) suffer from iron deficiency [3,4].
Conversely, if iron is consumed in excessive amounts, iron concentration rises to toxic
levels , a condition called hemochromatosis [3,5,6]. Both conditions can prove fatal.
Hence, the uptake, use, and metabolism of iron must be tightly regulated to curb its
potentially deleterious biological effects.

Iron Uptake
Iron is one of the most abundant elements in the earth's crust. It is widely used
both in organic and inorganic processes. One of the biggest problems facing cells when
trying to uptake iron is the relative insolubility of ferric hydroxide and other compounds
from which iron must be extracted for use . The solubility product of ferric hydroxide is
2. 79x 10-39 [7].

The aqueous environment of the cytosol is an inhospitable host for iron

extraction from insoluable iron compounds . Of the 18 mg of iron consumed daily, only
about one milligram is usually absorbed [8]. This generally is enough to compensate for
the small loses of iron from the body, principally in the bile. However, the rate of iron
uptake is not static, but varies according to the needs of the body. Iron uptake is greatly
increased in pregnant and menstruating women [8].

Ascorbic acid, or Vitamin C,

increases iron uptake, as does ingestion of meat [8]. The rate is variable and usually
functions, although not perfectly, to maintain the iron balance in the body .
The combination

of the hydrophobic

plasma membrane

and the relative

insolubility of iron creates a physiochemical barrier for intracellular iron uptake. In order
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to overcome this barrier, iron is chelated and transferred from one organic ligand to
another, thus minimizing the amount of free intracellular iron. This process differs in
prokaryotic

and eukaryotic cells.

understood

[9-11 ], but is thought to resembles the uptake of iron by the yeast,

The uptake of iron by the human body is not fully

Saccharomyces cervisiae [ 12]
S. cervisiae has two systems for uptake of iron: a low-affinity system and a highaffinity system [13,14].

The low-affinity system depends on cytoplasmic membrane

proteins encoded by genes FETJ, FET2, and FET4 [11-13]. The FETJ and FET2 genes
encode for different reductase proteins and FET4 encodes for a protein transporter.

It

seems that these three proteins work together, along with Fet3 copper oxidoreductase , to
transport ferrous iron across the plasma membrane, and in the process , oxidizing it to
ferric iron . The high-affinity uptake system is more complicated.
oxidoreductase

It involves Fet3 copper

and a perm ease encoded by FTR 1 [ 14-17]. The complete mechanism is

still unknown and is being actively researched.

It is known, however , that a divalent

cation transporter , which is coupled to the membrane proton gradient in the intestinal
mucosa, is involved in iron uptake [ 18, 19].
In order for an increased rate in iron absorption, iron is generally reduced to
ferrous iron [20].

Ferrous iron is absorbed more rapidly than ferric iron [20].

Once

absorbed, iron may be quickly sequestered by transferrin, an iron carrying protein , in the
intestinal mucosa! cells [3] , thus eliminating any possible free iron. In order for the iron
to bind to transferrin , the iron must be reoxidized to ferric iron and chelated into an
"unreactive" complex [3]. The chelated iron is then transferred to other proteins, such as
blood plasma transferrin, and transported throughout the body in a safer, less toxic form .
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Although the ultimate source of iron is the diet, 9 billion red blood cells are
destroyed daily, yielding 20-25 mg of iron. Most of the iron is either recycled for use in
various biochemical processes or stored [8].

Iron Storage
Not all iron present in the body is used at the same time . A large portion of the
iron is sequestered and stored for later use. A large globular protein called ferritin is the
main storage protein for iron . Ferritin consists of an outer protein coat made of 24
subunits. Each subunit forms a four-helix bundle motif. In human ferritin, there are two
different subunits : light chain ferritin (molecular weight = 19 kDa) and heavy chain
ferritin (molecular weight = 21 kDa). The twenty-four subunits form a cubic array with
an empty core [21]. Inside this core is where the iron is stored . The exact mechanism of
iron loading into ferritin is still under investigation .
Two mechani sms for iron loading have been proposed . The most widely accepted
hypothesis is that initially, a physiological transfer of iron from transferrin to ferritin
occurs in which ferric iron is reduced to ferrous iron. The mechanism for this redox
reaction is still unknown. It is thought that a diffusible cytoplasmic protein catalyzes this
reaction . Once the iron has been reduced to ferrous iron and presented to the ferritin, it
has been suggested the iron is reoxidized by molecular oxygen to ferric iron for
deposition of iron in the core. This reoxidation is said to be catalyzed by the ferritin's
intrinsic ferroxidase activity present in the centers of helical bundles of the heavy chains
[22-26]. The proposed reaction for this process is:
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The biggest problem with this proposed mechanism is that hydrogen peroxide is formed .
As noted earlier , iron can catalyze the decomposition of hydrogen peroxide, producing
the hydroxyl radical, which will react with the first organic molecule it contacts , which
will most likely be the ferritin ferroxidase centers. This will lead to the eventual damage
or inactivation of the ferroxidase centers and the ferritin may lose its ability to properly
load and store iron. The second hypothesis for iron loading suggests that a cytoplasmic
blue-copper oxidase protein , called ceruloplasmin, catalyzes the oxidation of Fe(II) to
Fe(III), followed by deposition of the iron in the ferritin core. The proposed reaction for
this process is:
4 Fe 2+ + 0 2 + 4H+ ➔ 4Fe 3+ + 2H20
This mechanism presents iron to the ferritin in such a way as to not produce ROS [27),
thus eliminating the possibility of damaging the ferritin. It has been shown that in saline
solution at physiological pH, iron presented to apoferritin in the absence of ceruloplasmin
was not incorporated into the core [28).
Ferritin is not the only iron storage molecule . Hemosiderin , a protein that seems
to consist of ferritin partially degraded by lysosomes, also stores iron. It stores more iron
than ferritin [8). If too much iron is absorbed from the diet, deposits of hemosiderin can
accumulate in the liver in toxic amounts .
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Figure 1: Iron Protoporphrin IX (Heme) found in b-type cytochromes.

Iron Usage
Iron is used in many different proteins throughout the body . The most well
known protein is hemoglobin, the four-subunit blood oxygen carrier. Myoglobin, which
only contains one subunit, is a similar protein that transports and stores oxygen in the
muscle . Each of these proteins contain iron bound in a porphryin ring system. This
porphryin-iron ring complex is known as heme (Figure 1).

Heme is found in all

organisms except anaerobic Clostridia and lactic acid bacteria, and can have both
beneficial and deleterious effects [29].

In humans, there are many heme-containing

proteins including hemoglobin and myoglobin. Hemoglobin and myoglobin are not the
only heme containing proteins. Other proteins that include a heme group include, but are
not limited to, nitric oxide synthase, cyclooxygenase, and various cytochromes [29].
The details of the process by which iron is incorporated into protoporphryin IX,
the porphryin ring used to produce heme, are not known. It is evident, however, that the
enzyme ferrochelatase catalyzes the transfer of free ferrous iron into the ring [30].
Another mechanism of iron incorporation also includes the oxidation of ferrous to ferric
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iron by ceruloplasmin and be incorporated into heme by direct transfer from ferritin [31].
The study of heme production
incorporation

using recombinant

of iron into protoporphryin

human proteins in E. coli, for

IX has not been successful.

Research is

currently being done to determine other enzymes that may be needed to assist in this
process .

It has been shown that there is a docking site between the proteins

ferrochelatase and frataxin [32]. It is thought that frataxin serves as an iron chaperone to
aid in the insertion of iron into heme.
Heme is not the only form of ''usable" iron in the body. Iron also is used in ironsulfur proteins . This large family of proteins includes proteins such as ferredoxins,
rubredoxins,

and Rieske iron-sulfur proteins [33-35].

The most simple iron-sulfur

complex is the rubredoxin complex. This complex contains iron but no inorganic sulfur.
Iron is covalently attached in a distorted tetrahedron to four cysteine residues.

Another

type of iron-sulfur complex is the 2Fe-2S complex, in which 2 iron atoms are each
covalently attached to two cysteine residues and are linked together through bonds to two
inorganic sulfur atoms. There are also 4Fe-4S complexes. These complexes are usually
used in electron transport reactions.

Rieske iron-sulfur proteins are similar in structure .

The main difference between them and regular iron-sulfur complexes is that one of the
iron atoms is coordinated to 2 histidine residues rather that 2 cysteine residues.

This

complex is important in the cytochrome bc 1 complex (complex III) of the mitochondrial
electron transport chain [36].
When complexed into the right proteins, iron plays very crucial roles. However ,
the proteins wear out with use. When worn out, the proteins are degraded . In the case of
hemoglobin, the protein enters a proteosome and is digested into smaller peptide chains
and individual amino acids.

The proteosome, however, cannot degrade the heme

8
compontent and releases it to the cytoplasm. Free heme is dangerous to cells because it
induces oxidative stress and greatly increases cellular death [1].

Heme Metabolism
In order to cope with excess heme, a metabolic pathway evolved that provides for
the enzymatic breakdown of heme.

The central enzyme of this heme metabolism

pathway is heme oxygenase-1 (HO-1) [37]. Human HO-1 is a mitochondrial-membrane
bound protein that catalyzes the NADPH- and cytochrome P450 reductase-dependent
oxidation and breakdown of heme into carbon monoxide, biliverdin, and ferric iron [37].
The biliverdin produced is then reduced to bilirubin by biliverdin reductase , which is
conjugated for secretion [38].
Heme metabolism by heme oxygenase does eliminate heme, however it releases
ferrous iron , which can participate in further deleterious oxidations . This redox-active
iron must be removed from the cytoplasm in order to prevent such oxidations . Ferritin , a
protein with a very high capacity for storing iron [39], could be the protein that sequesters
this free iron. Recent research has shown that the up-regulation of heme oxygenase and
ferritin in endothelial cells is effecti ve in the protection of endothelium against the
damaging effects of exogenous heme and other oxidants [ 1]. The mechanism behind this
phenomenon has not been explained , however.
The hypothesis of this study is that iron released from heme degradation by HO-1
is loaded into ferritin , thus limiting the potential deleterious effects of free iron . In order
to test the hypothesis,

the genes encoding

for human HO-1 and ferritin were

simultaneously expressed in Escherichia coli strain B834. The strain was then exposed
to varying amounts of hemin.

Following incubation for 24-36 hours, the ferritin was
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purified . The amount of iron loaded into ferritin was determined by a modified version
of the reductive release assay determined by Thomas et al. [40], utilizing paraquat and
bathophenanthroline. If the hypothesis for this study is correct, it should be observed that
as the concentration of hemin is increased, more iron should be loaded into ferritin .

MATERIALS
The heme oxygenase-1 gene, obtained from Dr. Paul R . Ortiz de Montellano
(University of California) , was inserted into pCDFDuet-1, purchased from Novagen.
The plasmid containing a gene for ferritin H-chain homomer and the E. coli B834 cell
line used for simultaneously expressing ferritin and heme oxygenase-1 were provided by
Zane Davis (Utah State University).
M9 minimal medium was prepared using M9 Minimal salts and other chemicals
from Sigma. Hemin and chemicals used in ferritin unloading assay were purchased from
Sigma.
All water used was doubly deionized water.

METHODS

Bacterial Strains. E.coli strain XU-Blue was used for initial production of heme
oxygenase-1 in pCDFDuet-1 and E. coli strain B843 for the dual expression of heme
oxygenase-1 and ferritin.

Construction of modified pCDFDuet-1.

The gene encoding heme oxygenase-1

was amplified by the polymerase chain reaction (PCR) from the pUC 18 plasmid provided
by Paul Ortiz de Montellano.

The 5 ' -sense oligonucleotide primer ( 5' -CGCGGA TCCA
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Polymerase Chain Reaction (PCR)
Volume
Added(µI)
ddH2O
dNTPs
10xBuffer
MgCl2
Template
Forward
primer
Reverse
primer
Taq DNA
Polymerase

Final
Concentration

37
1
5
1

0 .2mM of each
1X
1.SmM
1µg/50µI

1

0.2µM

1

0.2µM

1

5 units

3

Table 1: PCR Conditions for Amplification of the gene encoding HO- I.

GAGCGTCCGCAAC-3 ') encoded for the BamHI restriction site.
oligonucleotide pnmer (5'-CCCAAGCTTTTAAGCCTGGGAGCGG-3')

The 3 '-antisense
encoded the

tennination codon for a truncated form of HO-1 ending at proline 23 amino acids from
the C-terminus immediately preceding a HindIII site.

The sequence encoding the

remaining 23 amino acids was not included because they form a signal sequence that
directs human heme oxygenase-1 to the mitochondria , which is not needed in this case.
PCR was perfonn ed using a Perkins Elm er PCR amplification 9600 Thermocycl er
System. The reaction mixture was according to concentrations given in Table 1. The
cycle consisted of an initial melting cycle of two minutes at 95°C followed by 30 cycles
of denaturation , annealing , and extension , followed by a final ten minute extension .
Denaturation was performed at 95°C for one minute, annealing at 55°C for one minute,
and extension at 74° C for two minutes (or ten in the last step). The PCR product was
purified using the QIAquick PCR Purification kit (Qiagen) and analyzed by agarose gel
electrophoresis for purity (Figure 2).
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Figure 2: Ethidium bromide agarose gel electrophoresis of the gene H0-1 . The gene H0-1 was
amplified using PCR and analyzed by agaro se gel electrophore sis after staining by ethidium bromide . Th e
first column is the H0 - 1 gen e and the second column is the Fermenta s 1kb Gene Ladder.

The pCDFDuet-1 plasmid and gene insert were sequentially digested , first with
BamHl , followed by Hindlll.

The initial digestion contained 4 µg of DNA , 10 units * of

BamHI , 2 µl of BamHI Buffer (Fermentus) , and water , for a final reaction volume of 20

µI. The solution was incubated at 37° C for 2 hours and product purified using QIAquick
PCR Purification kit. A second digestion was performed using the total product obtained
from the previous step (approx . 2 µg DNA in 30 µl of storage buffer) , 10 units of HindIII ,
4 µl of Buffer R (Fennentus) , and water, for a final reaction volume of 40 µI. Analysis
by agarose gel electrophoresis of pCDFDuet-1 digested with a single enzyme revealed
that both Hindlll and BamHI were successful at cutting the plasmid .
Ligation of the insert into the digested pCDFDuet-1 plasmid was performed at 1:4
and 1 :6 plasmid-to-insert concentrations , using 100 ng of digested pCDFDuet-1 in each
ligation mixture.

The 1:4 reaction contained 180 ng of digested gene insert and 1:6

contained 240 ng. A negative control contained no gene insert. Each reaction mixture

• 1 unit defined as the amount of enzyme required to completely digest 1 µg of substrate DNA in a 50 µI
reaction in 60 minutes.
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contained 2.5 unit st of T4DNA ligase.

Reactions were incubated at 16° C overnight

(about 16 hours). T4DNA ligase was then denatured by incubating the reaction mixtures
at 65° C for 10 minutes.
Ligation products were directly used for transformation . Transformation using E.

coli strain XLl-Blue

was performed

as outlined

by Stratagene

for XLl-Blue

Supercompetent Cells . Four separate transformations were performed, each containing
100 µl of XLl-Blue cells. Each was incubated on ice with 1.7 µl of ~-mercaptoethanol
for IO minutes. Following incubation , 3 µl of each ligation reaction was added to three of
the transformation mixtures . To the fourth was added 50 ng of undigested pCDFDuet-1
to act as a positive control. The transformation mixtures were then incubated on ice for
30 minutes , followed by a heat shock step at 42 ° C for 30 seconds. The mixtures were
then incubated on ice for an additional 2 minutes . Following incubation , 500 µl of SOC
medium heated to 42 ° C was added to each transformation mixture, followed by
additional incubation in a rotating shaker at 37° C at 225-250 rpm for 45 minutes.
Following incubation , 100 µl of each transformation volume was plated separately on
agar plates containing streptomycin and incubated for 24 hours at 37° C.
Colonies were harvested from the 1 :6 dilution plate and grown in 3 ml of LB
medium containing streptomycin.

Following incubation for 10 hours, 1 ml was used to

analy ze for successful ligation and transformation . Plasmid DNA was purified using
Multipore Purification System and analyzed via PCR for incorporation of HO-1 gene.
Further confirmation of gene incorporation was obtained by DNA sequencing . Colonies
showing successful incorporation of HO-1 were then grown in 100 ml cultures and their
plasmid DNA purified.
t 1 unit of enzyme catalyzes the incorporation of IO nmoles of deoxyribonucleotides into a polynucleotide

in 30min at 70°C.
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Simultaneous Expr ession of H0-1 andferritin in E. coli. The plasmid containing
the gene for HO-1 was transformed into a B834 strain already containing the gene
encoding ferritin H-chain homomer according to the procedure given previously for
transformation into XLl-Blue

cells.

Transformed cells were plated on agar plates

containing ampicillin, streptomycin, and chloramphenicol and incubated at 37° C for 24
hours.

All colonies that grew were cultured and analyzed for incorporation of both

ferritin and H 0-1 genes using PCR.
LB medium containing ampicillin, streptomycin, and chloramphenicol
inoculated with cells containing both ferritin and HO-1 genes.

was

Cultures were incubated

for about 8 hours at 37° C while shaking at 225 rpm. Ten milliliters were then removed
and spun at 7100 rpm (6000 x g) in a Sorval SS-34 rotor at 4° C for 20 minutes. The
supernatant was decanted and cells resuspended in 5 ml of M9 medium containing
ampicillin, streptomycin , and chloramphenicol. Larger cultures of M9 medium (500 ml)
were inoculated with this suspension and incubated at 37° C while shaking at 180 rpm
until they reached an absorbance A 600= ~0.8. Each culture was then induced by addition
of 0.119 g of isopropylthiogalactopyranoside (IPTG) . Incubation was continued for six
more hours. Some cells from each culture were removed, lysed, and ran on SDS-PAGE
to check for production of both ferritin and HO-1.

Degradation of Hemin. Four cultures were grown in M9 medium as described
above . Three cultures contained the B834s with both HO-1 and ferritin genes.

The

fourth culture only had ferritin to serve as a control. Hemin, dissolved in 1 ml of 1 M
NaOH, was added to the four cultures according to Table 2. Each culture was incubated
for another 24 to 36 hours at 37°C while shaking at 180 rpm.
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Addition of Hemin to Cells containing H0-1 and Ferritin
Proteins present

Hemin Final Concentration (µMl

HO-1 & Ferritin

15

2

HO-1 & Ferritin

50

3

HO-1 & Ferritin

100

Ferritin

15

Control

Table 2: Addition of Hemin. Three cultures and a control were incubated with differing amount s of
hemin to test for the incorporation of iron into ferritin .

Purification of Ferritin. Cells from each culture were harvested by centrifugation
for 12 minutes at 5500 rpm (5000 x g) at 4° C using a GS-3 rotor.

Cells were

resuspended m 5 ml of Lysis Buffer (DNase at l0µg/ml , RNase at l0µg/ml, and
lysozyme at lmg/ml in 50 ml of 50mM Tris, pH 7.0). The cells were then lysed by
freezing in liquid N 2 followed by subsequent thawing in a 42° C water bath . This
freeze/thaw process was repeated three times to ensure complete lysis . The lysed cells
were then centrifuged at 10,000 x g (9,000 rpm) for 20 minutes using a SS-34 rotor in a
Sorval RC-3B centrifuge to remove unwanted cellular debris . The supernatant was
decanted and recentrifuged at 43,000 x g (19,000 rpm) for 20 minutes using a SS-34
rotor . The supernatant was saved and pellet discarded.

The supernatant was then added

to a pre-equilibrated t DEAE-Sepharose column. The column was sequentially washed
according to the sequence in Table 3 and fractions from each wash collected . Proteinrich fractions were identified using SDS-P AGE and pooled. The pooled fractions were
then concentrated to 1 ml using a YM-100 filter membrane (100 kDa molecular weight
cut-off) . The concentrated solution was then heat-treated at 65° C for 15 minutes in a

t Pre-equilibrated with I bed volume of 1 N NaOH, I bed volume of2 N NaCl at pH 7.0, and 6 bed
volumes of 50 mM Tris at pH 7 .0.

15

DEAE Column Elution

Eluate

1 bed volume at pH 7.0
50 mM Tris

2

50 mM NaCl/50 mM Tris

3

100 mM NaCl /50 mM Tris

4

150 mM NaCl/ 50 mM Tris

5

200 mM NaCl/50 mM Tris

6

2 M NaCl

Table 3: Purification of Ferritin by DEAE-Sepharose anion exchange chromatography. The
eluate from each step was analyzed by SDS-P AGE for the presence of ferritin. It was found that eluates 4
and 5 contained the ferritin.

water bath, followed by centrifugation at 5,000 x g (8,000 rpm) for 20 minutes in a table
top centrifuge to remove denatured proteins . The supernatant was chromatographed over
a Sepharose CL6B size exclusion column at 4° C using Chelex-100 (Sigma) treated 50
mM NaCl (pH 7.0) at a flow rate of 0.3 ml per minute. A Bradford assay was done to
identify protein-rich fractions , followed by SDS-PAGE to identify fractions containing
pure ferritin [41] . These were pooled and concentrated to 1 ml and another Bradford
assay performed to determine protein concentration .

D etermination of Iron Content. The amount of iron loaded into ferritin for each
sample was determined using an iron unloading assay described by Thomas and Aust
[40] with some modifications . This assay utilizes the iron chelator , bathophen-anthroline
sulfonate (c=0.002214 µM· 1cm· 1) , to quantitatively determine the amount of iron that is
reductively released from ferritin.

The assay was conducted in a 1 ml volume. To

conduct the assay, a mixture of 0.25 mM paraquat , 1.0 mM bathophenanthroline
sulfonate, 5 mM glucose in 50 mM NaCl was purged with argon for 5 minutes. Ferritin
was then added (concentrations ranging from 20 to 40 ng), along with 0.1 units of P450
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reductase, 10 units of glucose oxidase, and 500 units of catalase. This was then allowed
to sit for 5 minutes to ensure that the incubation mixture was anaerobic.

The reaction

was started by adding NADPH (0.3 mM) to the mixture and taking a continuous
absorbance using a Shimadzu UV-2101PC UV-VIS Scanning Spectrophotometer at 535
nm.

The maximum A 535 was recorded for each run and concentration of iron-

bathophenanthroline determined by A=

E

1 c, where 1 equals 1 cm, i::=0.002214 µM- 1cm- 1,

and c is the concentration of reacted bathophenanthroline, which is directly proportional
to the amount of iron released. The amount of iron released per ferritin molecule was
then determined algebraically.

RESULTS
Construction of modified pCDFDuet-1 and simultaneous production of ferritin
and HO-I . Successful incorporation of HO-1 into pCDFDuet-1 was verified using PCR
and gene sequencing . When incubated in LB medium and induced by addition of IPTG ,
the medium turned green due to the accumulation of biliverdin. This is consistent with
the results of Ortiz de Montellano in which he stated that E. coli "have a reductase
activity capable of supporting the catalytic turnover of [HO-1]. [42]"
When the modified pCDFDuet-1 was transformed into B834's already containing
the gene for ferritin, one colony grew.

The colony was harvested, cultured, and the

presence of both genes was confirmed by PCR.
Growth of the culture in M9 medium followed by induction by IPTG addition did
not lead to a change in color, as it did LB medium. However, SDS-PAGE revealed that
both proteins were produced.
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Figure 3: Total Iron Assay for Iron in Ferritin. Ferritin was purified from bacteria grown on
differing concentrations of hemin . Iron was released from ferritin by paraquat in the presence of
bathophenanthroline . Absorbance of bathophenanthroline -iron complex was measured at 535nm. The
conce ntration ofhemin in the media is as follows: b) 100 µM hemin, c) 50 µM hemin, d) 15 µM hemin , e)
Negative Control (15 µM hemin , no HO-I gene). Trace a is th release of iron from control ferritin, loaded
with iron in vitro. The data were obtained in triplicate but the data shown is from one assay .

Degradation of Hemin. Hemin, a dark red brown solid, was dissolved in NaOH,
and

added

to

the

samples

as

outlined

111

Table

4.

Upon

addition

of

the hemin, the cultures turned different shades of brown, the darker brown corresponding
to the higher concentrations of hemin . Incubation of the cultures for 24 to 36 hours led to
a slight change in color, with each culture containing H0-1 becoming more green.

The

control, which did not contain H0-1 , showed no noticeable color changes.

Purification of Ferritin and Determination of Iron Loaded into Ferritin . Ferritin
.

was purified from each sample and the protein concentrations determined by the Bradford
method [41]. The iron was released reductively from ferritin by the cation free radical of
paraquat and the absorbance of bathophenanthroline-iron measured at 53 5 nm (Figure 3).
Each sample, excluding the positive control, was analyzed in triplicate . Average iron
content per ferritin molecule was then calculated and results tabulated (Table 4).
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Amount of Iron in Ferritin Determined by
Reductive Release of Iron from Ferritin by
The Cation Free Radicals of Paraquat

Sample

Hemin cone .

Iron

(µM)

(atoms Fe/Ferritin)

15

2.9 (±0.3)

15

6.7 (±0.4)

2

50

22.4(±0.4)

3

100

36.3(±0.6)

+ control

NA

329

-- control

Table 4: Iron content in from ferritin purified fom bacterial cells containing heme oxygenase-1 and grown
on media containing hemin. The average amount of iron atoms unloaded per ferritin H-chain homomer
was determined using the total iron content and the protein concentration of each sample. Each sample
assay was performed in triplicate, except for the + control. The + control was a sample of loaded ferritin
H-chain homomer. The data are reported as the average with standard deviation.

DISCUSSION
The results of this study indicate that iron released during the degradation of heme
by heme oxygenase-1 is loaded into ferritin. As the concentration of heme increased in
the medium, the amount of iron loaded into ferritin increased. This is especially evident
when comparing Sample 1 with Control 1. Control 1 does not contain the human heme
oxygenase-1 gene . Sample 1, which contained heme oxygenase-1, showed a 2.3-fold
increase for iron loaded into ferritin.

This increase suggests that the iron released

following heme degradation is sequestered by the cell into ferritin in order to eliminate
the potential deleterious effects of free iron. This cytoprotective mechanism explains
why up-regulation of heme oxygenase-1 and ferritin has proven effective in shielding
cells from deleterious effects of free heme [ 1]. The iron released by heme degradation is
loaded into ferritin, thus limiting the potential deleterious effects of free iron.
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